Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Selzman

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Expert Opinion on Pharmacotherapy|May 5, 2001
Current approaches to therapy for vascular injuryC H Selzman
Annals of Vascular Surgery|December 5, 1998
Thrombophilia and activated protein C resistanceC H Selzman, T A Whitehill, W C Krupski
Surgery|March 17, 1999
Surgical implications of therapeutic angiogenesisM A Zimmerman, C H Selzman, A H Harken
The Surgical Clinics of North America|April 1, 1997
Unusual causes of mesenteric ischemiaW C Krupski, C H Selzman, T A Whitehill
The Annals of Thoracic Surgery|June 28, 2001
Therapeutic implications of inflammation in atherosclerotic cardiovascular diseaseC H Selzman, S A Miller, A H Harken
Archives of Surgery (Chicago, Ill. : 1960)|March 20, 2001
The case for beta-adrenergic blockade as prophylaxis against perioperative cardiovascular morbidity and mortalityC H Selzman, S A Miller, M A Zimmerman, et al.
The Annals of Thoracic Surgery|June 4, 1999
The NFkappaB inhibitory peptide, IkappaBalpha, prevents human vascular smooth muscle proliferationC H Selzman, B D Shames, R C McIntyre, et al.
Surgery|August 26, 1998
Class II cytokine receptor ligands inhibit human vascular smooth muscle proliferationC H Selzman, B D Shames, T A Whitehill, et al.
Journal of Molecular and Cellular Cardiology|May 29, 1998
Interleukin-10 inhibits human vascular smooth muscle proliferationC H Selzman, R C McIntyre, B D Shames, et al.
Archives of Surgery (Chicago, Ill. : 1960)|June 24, 1998
Genes don't countB D Shames, C H Selzman, X Meng, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Expert Opinion on Pharmacotherapy|May 5, 2001
Current approaches to therapy for vascular injuryC H Selzman
Annals of Vascular Surgery|December 5, 1998
Thrombophilia and activated protein C resistanceC H Selzman, T A Whitehill, W C Krupski
Surgery|March 17, 1999
Surgical implications of therapeutic angiogenesisM A Zimmerman, C H Selzman, A H Harken
The Surgical Clinics of North America|April 1, 1997
Unusual causes of mesenteric ischemiaW C Krupski, C H Selzman, T A Whitehill
The Annals of Thoracic Surgery|June 28, 2001
Therapeutic implications of inflammation in atherosclerotic cardiovascular diseaseC H Selzman, S A Miller, A H Harken
Archives of Surgery (Chicago, Ill. : 1960)|March 20, 2001
The case for beta-adrenergic blockade as prophylaxis against perioperative cardiovascular morbidity and mortalityC H Selzman, S A Miller, M A Zimmerman, et al.
The Annals of Thoracic Surgery|June 4, 1999
The NFkappaB inhibitory peptide, IkappaBalpha, prevents human vascular smooth muscle proliferationC H Selzman, B D Shames, R C McIntyre, et al.
Surgery|August 26, 1998
Class II cytokine receptor ligands inhibit human vascular smooth muscle proliferationC H Selzman, B D Shames, T A Whitehill, et al.
Journal of Molecular and Cellular Cardiology|May 29, 1998
Interleukin-10 inhibits human vascular smooth muscle proliferationC H Selzman, R C McIntyre, B D Shames, et al.
Archives of Surgery (Chicago, Ill. : 1960)|June 24, 1998
Genes don't countB D Shames, C H Selzman, X Meng, et al.
Pageof 4